ASSEMBLY BIOSCIENCES, INC.
Current- Director 2019 to present
Executive record
Alpha ID: alpha:person:john-g-mchutchison-a-o-m-dVersion: public-0As of: 2026-10-01
Connect capital, control, accountability, and evidence.
Dr. McHutchison has served as Chief Executive and Chairman of Tune Therapeutics, Inc. since March 2025. He previously served as Chief Executive Officer and President of Assembly Biosciences from August 2019 until December 2022, and as Chief Scientific Officer and Head of R&D at Gilead. He is an internationally recognized leader in infectious, liver and gastrointestinal diseases with extensive clinical development and innovation experience.
Alpha editorial summary written from the cited sources below. It does not change any Claim on this record.
No published Claims are available in this section of the public record. This does not establish that the information is undisclosed or that no relevant facts exist.
Review evidence coverageAlpha has not published independence, related-party, proceedings or disciplinary Claims for this record. This is not a finding that none exist.
Only disclosed facts and public registers appear here. Executive records carry no credit, personal litigation, background screening or underwriting views. None observed is not a clearance.
4 evidence records, matching Agent View. Records may refer to different locations or observations in the same document. This count is not a count of independent corroborating sources.
sec filing · Source published: Apr 22, 2026 · Retrieved: May 15, 2026
sec filing · Source published: Apr 22, 2026 · Retrieved: May 15, 2026
sec proxy · Source published: Apr 22, 2026 · Retrieved: Apr 24, 2026
public source · Source published: Date unavailable · Retrieved: Date unavailable
No published record changes are available in this projection.
Identity
unclaimed
Evidence
corroborated
Evaluation
Unknown
Monitoring
Unknown
Authority
Unknown
Freshness
Observed 2026-10-01